Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new nerve block ease shoulder pain after chest surgery?

NCT ID NCT07768826

Symptom relief Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This trial compares two ultrasound-guided nerve blocks for managing pain after thoracotomy (chest surgery). One is the serratus posterior superior intercostal plane block (SPSIPB), a newer technique, and the other is the standard thoracic paravertebral block (PVB). The study includes adults aged 18-75 undergoing elective thoracotomy. Researchers will measure pain intensity, especially shoulder pain, and assess breathing recovery using a spirometer. The goal is to see if SPSIPB can provide effective pain relief and improve recovery compared to PVB.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Serratus Posterior Superior Intercostal Plane Block (SPSIPB) with bupivacaine, compared to Thoracic Paravertebral Block (PVB)
What this could lead to
If SPSIPB proves as effective as PVB, it could offer a simpler, safer option for managing post-thoracotomy pain, improving recovery and breathing.
What could go wrong
This is a small, early-stage comparison (66 patients) and results may not apply broadly. Nerve blocks carry risks like bleeding, infection, or incomplete pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 66 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Patients scheduled to undergo elective thoracic surgery via thoracotomy * Patients aged between 18 and 75 years * Patients classified as American Society of Anesthesiologists (ASA) physical status I-III * Patients who provide written informed consent to participate in the study Exclusion Criteria * Patients with a known allergy or hypersensitivity to local anesthetic agents * Patients with coagulation disorders or those receiving anticoagulant therapy * Pregnant or breastfeeding women * Patients with impaired consciousness or inability to communicate effectively * Patients in whom block administration is unsuccessful * Patients who decline regional block administration * Patients with mental or cognitive impairment precluding reliable preoperative pain assessment * Patients with intolerance to or contraindications for morphine or other opioid medications * Patients who voluntarily choose to withdraw from the study at any stage of the research process * Patients who develop intraoperative surgical complications * Patients who experience hemodynamic complications during the perioperative period * Patients who develop serious postoperative medical complications requiring intensive care unit admission, reoperation, or other major medical interventions * Patients with incomplete follow-up data or in whom opioid consumption cannot be accurately assessed due to technical malfunction of the patient-controlled analgesia (PCA) device will be excluded from the final analysis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postthoracotomy pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postthoracotomy pain

Contacts and locations

Locations

  • Ankara bilkent şehir hastanesi

    Ankara, Çankaya, Turkey (Türkiye)